Arya Krisna Manggala

Arya Krisna Manggala

Auto-generated profile, based on publicly available information

Arya Krisna Manggala

Department of Child Health, Faculty of Medicine Udayana University, Ngoerah Hospital, Denpasar, Indonesia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2018 in Paediatrica Indonesiana
Verified
Journal Article
Open access
PDF file
AMArya Krisna Manggala
Arya Krisna Manggala
KKKomang Wiswa Mitra Kenwa
Komang Wiswa Mitra Kenwa
MKMade Me Lina Kenwa
Made Me Lina Kenwa
ASAnak Agung Gede Dwinaldo Putra Jaya Sakti
Anak Agung Gede Dwinaldo Putra Jaya Sakti
ASAnak Agung Sagung Sawitri
Anak Agung Sagung Sawitri
Background Childhood stunting (low height-for-age) still remains a global health problem because it increases the risk of disturbances in growth and development as well as mortality. The prevalence of stunting in Bali is 32.5%, with the highest in Gianyar District at 41%. However, little is known about the risk factors of stunting children in Gianyar. Objective  To investigate the risk factors of stunting in children aged 24-59 months in Gianyar. Methods  This cross-sectional study involved 166 children, collected consecutively, aged 24-59 months, who visited the integrated health posts in 13 community health centers in Gianyar District, Bali from September to November 2016. Stunting is defined as -2SD below the WHO height-for-age z-score (HAZ), according to sex. Statistical analyses were done with Chi-square and multivariate logistic regression tests. Results Of 166 subjects, 37 (22.3%) children were stunted. Multivariate analysis revealed that low paternal education (AOR 2.88; 95%CI 1.10 to 7.55; P=0.031), maternal height less than 150 cm (AOR 7.64; 95%CI 2.03 to 28.74; P=0.003), high risk maternal age (AOR 4.24; 95%CI 1.56 to 11.49; P= 0.005), low birth weight (AOR 5.09; 95%CI 1.03 to 25.31; P=0.047), and low birth length (AOR 9.92; 95%CI 1.84 to 53.51; P=0.008) were strongly associated with stunting. Conclusion  Risk factors for stunting in children are low paternal education, maternal height less than 150 cm, high risk maternal age, low birth weight, and low birth length.

15 September 2020 in Clinical and Experimental Pediatrics
Verified
Journal Article
Open access
PDF file
DWDyah Kanya Wati
Dyah Kanya Wati
AMArya Krisna Manggala
Arya Krisna Manggala
The widespread and contagious coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has become a burden in the global health domain. The subsequent discovery of the virus features and pathogenesis, and prompt and adequate management are still lacking and remain inconclusive. Children usually present milder symptoms than adults, and management focuses on providing symptomatic and respiratory supports. Several treatment modalities, including the utilization of mechanical ventilation (MV), antivirals, immune-modulating drugs, or other agents, may present promising results in reducing the symptoms of COVID-19, particularly in severe cases. Although no randomized clinical trials have been published to date, it is interesting to explore potential modalities for treating COVID-19 in children, based on review articles, case reports, and recent guidelines.

15 June 2025 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
AMArya Krisna Manggala
Arya Krisna Manggala
JAJustika Usmadhani Aulya
Justika Usmadhani Aulya
JFJonny Karunia Fajar
Jonny Karunia Fajar
DWDyah Kanya Wati
Dyah Kanya Wati

29 December 2025 in Trends in Pediatrics
Verified
Journal Article
Open access
PDF file
AMArya Krisna Manggala
Arya Krisna Manggala
NPNi Putu Siadi Purniti
Ni Putu Siadi Purniti
ISIda Bagus Subanada
Ida Bagus Subanada
AMAyu Setyorini Mestika Mayangsari
Ayu Setyorini Mestika Mayangsari
IKI Putu Gede Karyana
I Putu Gede Karyana
NTNi Made Adi Tarini
Ni Made Adi Tarini
Diagnosing abdominal tuberculosis (TB) is challenging due to its uncommon symptoms and limited diagnostic tools, which can delay treatment and increase mortality. We present two cases of abdominal TB diagnosed using different approaches. In case 1, a 6-year-old girl with a month-long history of ascites, whose father had treatment-resistant TB, was evaluated. The tuberculin test was positive, but the Xpert MTB/RIF Ultra assay was negative. Laparoscopy revealed miliary nodules, and histopathology confirmed the presence of granulomas with Langhans giant cells. In case 2, a 1-year-old girl presented with seven months of ascites and no known TB contact. The tuberculin test was negative, but an abdominal CT scan showed hepatic TB. The in-house polymerase chain reaction (PCR) for TB targeting the IS3-like element IS987 family transposase in our laboratory was positive. Both patients were diagnosed with abdominal TB, treated with the extrapulmonary (EPTB) regimen, and showed significant improvement. Diagnosing abdominal TB is complex, requiring a thorough history and adequate examination support. This might prevent delays in treatment that potentially increase complications.

31 May 2026 in Acute and Critical Care
Verified
Journal Article
Open access
AMArya Krisna Manggala
Arya Krisna Manggala
DWDyah Kanya Wati
Dyah Kanya Wati
ISIda Bagus Gede Suparyatha
Ida Bagus Gede Suparyatha
IHI Nyoman Budi Hartawan
I Nyoman Budi Hartawan
Background: Sepsis is a leading cause of mortality and morbidity in children. While the Pediatric Logistic Organ Dysfunction-2 (PELOD-2) score is a common predictor of mortality, it does not account for the use of inotropic drugs or sepsis markers, which are addressed by the vasoactive-inotropic score (VIS) and measurements of procalcitonin levels. Combining these components enables faster and more accurate predictions of mortality risks. Therefore, this study aimed to develop a new stratification model of mortality risks by integrating PELOD-2, VIS, and procalcitonin among children with septic shock.Methods: A single-center, three-year, retrospective cohort study was conducted in the pediatric intensive care unit of a tertiary hospital. Children aged 1 month to 18 years and diagnosed with septic shock between 2022 and 2024 received vasoactive and/or inotropic support within 24 hours of diagnosis. PELOD-2 scores and procalcitonin levels were recorded at diagnosis. The cutoff values for PELOD-2, VIS, and procalcitonin were determined using receiver operating characteristic curves. Multivariate analysis was used to generate a final equation and validated with the Hosmer-Lemeshow goodness-of-fit test.Results: A total of 101 children were included, with a mortality rate of 78.2%. The optimal cutoff values were a PELOD-2 score ≥8 (sensitivity, 88.6%; specificity, 72.7%), a VIS score ≥11.5 (sensitivity, 78.5%; specificity, 72.7%), and a procalcitonin level ≥5 ng/ml (sensitivity, 74.7%; specificity, 68.2%). Multivariate analysis revealed significant associations with outcomes: PELOD-2 (adjusted odds ratio [aOR], 12.75; P<0.001), VIS (aOR, 4.686; P=0.02), and procalcitonin (aOR, 4.245; P=0.029). The new mortality risk prediction model achieved a range of 12.8% to 97.39% and exhibited excellent discriminator power (area under the curve, 0.911). The Hosmer–Lemeshow test confirmed good calibration.Conclusions: The new scoring approach that refines stratification of mortality risks by incorporating PELOD-2, VIS, and procalcitonin is a more comprehensive predictor.